Government Affairs, Policy and Reimbursement including:
- Monitor, analyze and explain legislative, regulatory and reimbursement landscape issues that impact the biopharmaceutical industry
- Proprietary reimbursement and policy planning; We simplify the complexities of Medicare, Medicaid, product reimbursement and evidence-based medicine and explain the business implications
- Portfolio and pipeline planning based upon a changing payor, legislative and regulatory environment
- Legislative and regulatory advocacy
Government Procurement and Non-Dilutive Funding Strategies including:
- Provide expert advice on business development, proposal submission and contracting for biopharma companies pursuing work or applications of their technology within U.S. government agencies
- Biodefense, countermeasure development, preparedness for emergent and novel diseases
Ally Development including:
- Build coalitions and recruit third-party allies with common interests
Market Research and Strategic Analysis including:
- Conduct qualitative and quantitative research to obtain a comprehensive understanding of our clients' key customers including managed markets, public and private payors and healthcare providers
- Analysis of managed care and healthcare provider customers to help clients identify effective account management tactics and strategies
- Provide guidance on optimizing customer relationships to maximize clients' return on investment
Strategic Planning including:
- Environmental assessments of critical healthcare issues and market trend analysis to determine key business implications
- Analysis of clients' strengths, weaknesses, opportunities and threats to determine effective competitive positioning and performance initiatives
Group Process Facilitation and Consensus Building including:
- Plan, facilitate and moderate advisory board and strategic business meetings with key internal and external stakeholders
